These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 6366566)

  • 21. The majority of epidermal Merkel cells are non-proliferative: a quantitative immunofluorescence analysis.
    Vaigot P; Pisani A; Darmon YM; Ortonne JP
    Acta Derm Venereol; 1987; 67(6):517-20. PubMed ID: 2451378
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of 5-fluoro-2'-deoxyuridine (FdUrd) on 5-bromo-2'-deoxyuridine (BrdUrd) incorporation into DNA measured with a monoclonal BrdUrd antibody and by the BrdUrd/Hoechst quenching effect.
    Ellwart J; Dörmer P
    Cytometry; 1985 Nov; 6(6):513-20. PubMed ID: 2415309
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Using monoclonal antibodies in bromodeoxyuridine-DNA analysis.
    Dolbeare F; Kuo WL; Beisker W; Vanderlaan M; Gray JW
    Methods Cell Biol; 1990; 33():207-16. PubMed ID: 1707484
    [No Abstract]   [Full Text] [Related]  

  • 24. Mapping of the pattern of DNA replication in polytene chromosome from Chironomus thummi using monoclonal anti-bromodeoxyuridine antibodies.
    Allison L; Arndt-Jovin DJ; Gratzner H; Ternynck T; Robert-Nicoud M
    Cytometry; 1985 Nov; 6(6):584-90. PubMed ID: 3905301
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Monoclonal antibodies against bromodeoxyuridine.
    Cytometry; 1985 Nov; 6(6):499-662. PubMed ID: 4064835
    [No Abstract]   [Full Text] [Related]  

  • 26. Immunocytochemical labeling of S-phase cells of human tumors by monoclonal antibodies in vitro.
    Hu YQ; Barrows GH
    Chin Med J (Engl); 1988 Apr; 101(4):263-6. PubMed ID: 3138085
    [No Abstract]   [Full Text] [Related]  

  • 27. S-phase detection with an antibody to bromodeoxyuridine. Role of DNase pretreatment.
    Gonchoroff NJ; Katzmann JA; Currie RM; Evans EL; Houck DW; Kline BC; Greipp PR; Loken MR
    J Immunol Methods; 1986 Oct; 93(1):97-101. PubMed ID: 3772110
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chromatin assembly factor 1 (CAF-1) colocalizes with replication foci in HeLa cell nuclei.
    Krude T
    Exp Cell Res; 1995 Oct; 220(2):304-11. PubMed ID: 7556438
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of monoclonal antibodies to bromodeoxyuridine.
    Vanderlaan M; Thomas CB
    Cytometry; 1985 Nov; 6(6):501-5. PubMed ID: 4064836
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Astrocytic proliferation in the brain adjacent to infarcted lesion: immunohistochemical study of astroprotein (GFAP) and bromodeoxyuridine (BrdU)].
    Takemoto O; Yoshimine T; Hayakawa T; Fujita T; Nakajima S; Taneda M; Mogami H
    No To Shinkei; 1989 Apr; 41(4):361-5. PubMed ID: 2765300
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rapid quantification of the toxic alga Prymnesium parvum in natural samples by use of a specific monoclonal antibody and solid-phase cytometry.
    West NJ; Bacchieri R; Hansen G; Tomas C; Lebaron P; Moreau H
    Appl Environ Microbiol; 2006 Jan; 72(1):860-8. PubMed ID: 16391128
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Methodologies for enumerating peripheral T lymphocytes.
    Lifter J
    J Clin Immunol; 1982 Jul; 2(3 Suppl):20S-23S. PubMed ID: 6752175
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Immunohistochemical demonstration of S-phase cells in bladder tumors by anti-bromodeoxyuridine monoclonal antibody. Using in vitro labeling method].
    Tsujihashi H; Matsuda H; Akiyama T; Kurita T; Uejima S
    Nihon Hinyokika Gakkai Zasshi; 1988 Mar; 79(3):423-7. PubMed ID: 3221593
    [No Abstract]   [Full Text] [Related]  

  • 34. Cell cycle kinetic measurements in an irradiated rat rhabdomyosarcoma using a monoclonal antibody to bromodeoxyuridine.
    Nüsse M; Afzal SM; Carr B; Kavanau K
    Cytometry; 1985 Nov; 6(6):611-9. PubMed ID: 4064841
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Double labeling of S-phase murine cells with bromodeoxyuridine and a second DNA-specific probe.
    Raza A; Spiridonidis C; Ucar K; Mayers G; Bankert R; Preisler HD
    Cancer Res; 1985 May; 45(5):2283-7. PubMed ID: 3986772
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rapid fluorometric detection of drug resistant tumour cells.
    deFazio A; Tattersall MH
    Br J Cancer; 1985 Oct; 52(4):633-6. PubMed ID: 3904800
    [No Abstract]   [Full Text] [Related]  

  • 37. The biology of myelodysplastic syndromes: unity despite heterogeneity.
    Raza A; Cruz R; Latif T; Mukherjee S; Galili N
    Hematol Rep; 2010 Jan; 2(1):e4. PubMed ID: 22184517
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In situ demonstration of tissue proliferative activity using anti-bromo-deoxyuridine monoclonal antibody.
    Veronese S; Gambacorta M; Falini B
    J Clin Pathol; 1989 Aug; 42(8):820-6. PubMed ID: 2475528
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Selective elimination of idiotype-binding cells in vivo by a drug-idiotype conjugate demonstrates the functional significance of these cells in immune regulation.
    Abu-Hadid MM; Bankert RB; Mayers GL
    Proc Natl Acad Sci U S A; 1988 Jun; 85(11):3990-4. PubMed ID: 2453882
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cellular proliferation in the anterior pituitary of the rat during the postnatal period.
    Carbajo-Pérez E; Watanabe YG
    Cell Tissue Res; 1990 Aug; 261(2):333-8. PubMed ID: 2401005
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.